RecQ helicases are key genome maintenance enzymes that function in DNA replication, recombination, and repair. In contrast to nearly every other identified RecQ family member, the RecQ helicase from the radioresistant bacterium Deinococcus radiodurans encodes three "Helicase and RNase D C-terminal" (HRDC) domains at its C terminus. HRDC domains have been implicated in structure-specific nucleic acid binding with roles in targeting RecQ proteins to particular DNA structures; however, only RecQ proteins with single HRDC domains have been examined to date. We demonstrate that the HRDC domains can be proteolytically removed from the D. radiodurans RecQ (DrRecQ) C terminus, consistent with each forming a structural domain. Using this observation as a guide, we produced a panel of recombinant DrRecQ variants lacking combinations of its HRDC domains to investigate their biochemical functions. The N-terminal-most HRDC domain is shown to be critical for high affinity DNA binding and for efficient unwinding of DNA in some contexts. In contrast, the more C-terminal HRDC domains attenuate the DNA binding affinity and DNAdependent ATP hydrolysis rate of the enzyme and play more complex roles in structure-specific DNA unwinding. Our results indicate that the multiple DrRecQ HRDC domains have evolved to encode DNA binding and regulatory functions in the enzyme.
binding and winged helix subdomains that are thought to be important for structural stability and interactions with DNA and proteins (25) (26) (27) . HRDC domains have been found in both ribonucleases and helicases, suggesting a broad role in nucleic acid binding (23) , and isolated HRDC domains from EcRecQ, Saccharomyces cerevisiae Sgs1, and human WRN all bind DNA, albeit with different structural preferences (28 -30) . RecQ proteins in which the HRDC domain has been inactivated can usually function as DNA-dependent ATPases and helicases but often have altered DNA binding activities. For example, removal or mutation of EcRecQ HRDC domain produces variants with normal helicase and ATPase activities but with altered structure-specific DNA binding properties (24, 30) . Similarly, removal or mutation of the HRDC domain in the human BLM protein greatly weakens its binding to and dissolution of double Holliday Junction (HJ) DNA (31) , although HRDC-lacking BLM protein is still able to able to hydrolyze ATP and unwind simpler DNA structures (32) . HRDC deletion variants from the S. cerevisiae Sgs1 also retain their basic helicase functions in vitro and, in most contexts, their activity in vivo (33) (34) (35) (36) .
DrRecQ contains a domain architecture similar to RecQ helicases from other organisms. However, in contrast to most other RecQ proteins, DrRecQ encodes three HRDC domains (HRDC1, HRDC2, and HRDC3, in order from N-to C-terminal) (Fig. 1) . In this report, we have described the structure-specific DNA binding, DNA-dependent ATP hydrolysis, and DNA unwinding properties of DrRecQ and of a panel of deletion variants that lack either individual HRDC domains or combinations of these domains. Our results indicate that each DrRecQ HRDC domain has a distinct effect on these activities. HRDC1 is required for high affinity DNA binding and is critical for unwinding HJ DNA. HRDC2 attenuates DrRecQ ssDNA binding but stimulates HJ binding; interestingly, HRDC2 also inhibits DNA unwinding. HRDC3 attenuates ssDNA and HJ DNA binding but appears to have no effect on DNA unwinding. In addition, successive removal of HRDC domains from the DrRecQ C terminus increases its maximal ssDNA-dependent ATP hydrolysis rates. Based on our findings, we propose a model where D. radiodurans RecQ activity is regulated by its HRDC domains.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of DrRecQ Constructs-D. radiodurans cell culture and genomic DNA isolation were carried out as previously described (37) . The recQ gene from D. radiodurans was amplified from strain R1 genomic DNA by the polymerase chain reaction. Products were cloned into the pET28.b bacterial expression vector (Novagen) using NdeI and XhoI restriction sites. Domain variants of DrRecQ were constructed similarly to create pMK102 (encoding residues 1-728, DrRecQ-2HRDC), pMK103 (residues 1-610, DrRecQ-1HRDC), pMK104 (residues 1-519, DrRecQ⌬C), pMK105 (residues 518 -824, 3HRDC), pMK106 (residues 534 -610, HRDC1), pMK107 (residues 654 -729, HRDC2), pMK108 (residues 751-824, HRDC3), pMK109 (residues 534 -729, HRDC1 ϩ 2), and pMK110 (residues 654 -824, HRDC2 ϩ 3). Each plasmid encodes a His 6 purification tag and thrombin cleavage site on the N terminus of the DrRecQ variant. The fidelity of all D. radiodurans recQ genes was confirmed by DNA sequencing.
E. coli BL21(DE3) cells transformed with pMK101 (or another DrRecQ variant expression vector) were grown in Luria-Bertani medium (38) supplemented with 50 mg/ml of kanamycin at 37°C with orbital shaking. Protein expression was induced by addition of 1 mM isopropyl-␤-D-thiogalactopyranoside to cells at mid-log phase (A 600 ϭ 0.6). Cells were harvested by centrifugation (10 min at 13,000 ϫ g) after 4 h of induction and frozen overnight at Ϫ80°C. Pellets were resuspended in lysis buffer (20 mM Tris, pH 8.0, 500 mM NaCl, 10% (v/v) glycerol, 1 mM 2-mercaptoethanol, 1 mM phenylmethylsulphonyl fluoride, 10 mM imidazole), lysed by sonication on ice, and clarified by centrifugation (30 min at 28,000 ϫ g). Soluble lysate was loaded onto a Ni 2ϩ -NTA column and washed with lysis buffer. His-tagged protein was eluted with lysis buffer adjusted to 250 mM imidazole and dialyzed overnight against lysis buffer lacking imidazole. Protein in the dialysate was cleaved with thrombin to remove the His tag (a Gly-Ser-His sequence remains on the N terminus) and passed over an additional Ni 2ϩ -NTA column to remove remaining contaminants. Unbound protein was concentrated and loaded onto a Sephacryl S-100 size exclusion column in 10 mM Tris, pH 8.0, 500 mM NaCl, 10% (v/v) glycerol, and 1 mM 2-mercaptoethanol. RecQ fractions were pooled and concentrated to Ͼ50 M, dialyzed against storage buffer (10 mM Tris, pH 8.0, 500 mM NaCl, 40% (v/v) glycerol, 1 mM 2-mercaptoethanol, and 0.5 mM EDTA), and stored at Ϫ20°C. All protein concentrations were determined by measuring A 280 in 6.0 M guanidine-HCl (39), and purity was assessed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
Limited Proteolysis of D. radiodurans RecQ-Purified DrRecQ was mixed with chymotrypsin at a 100:1 DrRecQ:protease ratio in 20 mM Tris, pH 8.0, 150 mM NaCl, 1 mM 2-mercaptoethanol, 1 mM EDTA at room temperature. Reactions were quenched at 0, 1, 5, 15, or 30 min by the addition of 10 mM phenylmethylsulfonyl fluoride and SDS gel running buffer, stored on dry ice, resolved by 10% SDS-PAGE, and stained with Coomassie Brilliant Blue. Proteolysis fragments were excised from the gel, digested with trypsin, and subjected to MALDI-TOF mass spectrometry (University of Wisconsin Mass Spectrometry facility) for identification of DrRecQ peptides retained in each band. In separate experiments, proteolysis fragments were transferred to polyvinylidene difluoride and subjected to N-terminal sequencing (Medical College of Wisconsin Protein/DNA facility).
Synthetic DNA Substrates-Synthetic oligonucleotides dT 28 , o18 (5Ј-AAGCACAATTACCCACGC-3Ј), o30 (5Ј-GCGTGGGTAATTGTG-CTTCAATGGACTGAC-3Ј), oHolliday1 (5Ј-GCCGTGATCACCAA-TGCAGATTGACGAACCTTTGCCCACGT-3Ј), oHolliday2 (5Ј-GA-CGTGGGCAAAGGTTCGTCAATGGACTGACAGCTGCATGG-3Ј), oHolliday3 (5Ј-GCCATGCAGCTGTCAGTCCATTGTCATGC-TAGGCCTACTGC-3Ј), oHolliday4 (5Ј-GGCAGTAGGCCTAGCAT-GACAATCTGCATTGGTGATCACGG-3Ј), 3Ј-fluorescein-labeled o18, 3Ј-fluorescein-labeled o30, and 5Ј-fluorescein-labeled oHolliday1 were purchased from MWG Biotech. 3Ј-OH substrate was created by annealing o30-o18 in equimolar amounts, forming an 18-base pair duplex region with a 12-base 3Ј-single-stranded extension. HJ substrate was created by annealing equimolar amounts oHolliday1, oHolliday2, oHolliday3, and oHolliday4, which forms a structure with four 20-base pair duplex arms extending from a central four-way junction. All substrates were annealed by boiling for 5 min and allowing the mixture to slow cool for 30 min at room temperature. For fluorescence polarization substrates, 3Ј-fluorescein-labeled o18 and 5Ј-fluorescein-labeled oHolliday1 oligonucleotides were incorporated into the 3Ј-OH and HJ structures and 3Ј-fluorescein-labeled o30 was used as ssDNA.
DNA Binding Assays-Purified DrRecQ variants were serially diluted in dilution buffer (20 mM Tris, pH 8.0, 50 mM NaCl, 1 mM 2-mercaptoethanol, 1 mM MgCl 2 , 0.1 g/liter of bovine serum albumin, 4% (v/v) glycerol). Diluted proteins were incubated with 1 nM DNA substrate for 20 min at room temperature in a total reaction volume of 100 l. The fluorescence polarization of each sample was measured at 25°C using a Panvera Beacon 2000 fluorescence polarization system with 490 and 535 nm excitation and emission wavelengths, respectively. The fraction of substrate bound in each sample was calculated by setting the anisot-ropy value of the fluorescein-labeled substrate in buffer alone (values were ϳ45 millianisotropy (mA) units) to zero and setting the anisotropy value at 10 M protein concentration (values were ϳ220 mA) to 100% bound. Reactions were performed in triplicate and are plotted as the average fraction DNA bound in the trials with error bars representing one S.D. Uncertainty in the estimated K d , app values was calculated by determining the standard deviation of the average K d , app from three independent trials.
DNA-dependent ATPase Assays-ATPase assays were performed as previously described (24) . 0.001-100 nM (molecules) dT 28 was used to stimulate the ATPase activity of the DrRecQ variants. Reactions were performed in triplicate; average specific activities and error bars representing one S.D. of the mean are plotted.
Helicase Assays-The 5Ј-end of oligonucleotides o18 and oHolliday 1 were phosphorylated by T4 polynucleotide kinase with [␥-32 P]ATP, annealed to their respective complimentary oligonucleotide(s) as described under "Synthetic DNA Substrates" above, resolved by 12% native PAGE, and isolated by electroelution. DNA substrates were dialyzed against 20 mM Tris, pH 8.0, 50 mM NaCl. DrRecQ variants were incubated with ϳ1 nM substrate for 30 min at room temperature in 20 mM Tris, pH 8.0, 50 mM NaCl, 1 mM 2-mercaptoethanol, 1 mM MgCl 2 , 1 mM ATP, 0.1 g/liter bovine serum albumin, and 4% (v/v) glycerol. Reactions were quenched with the addition of 11% (v/v) glycerol, 0.29% SDS, and 5 ng of unlabeled o18 or oHolliday1. Products were resolved by 12% native PAGE, dried, and imaged using a Amersham Biosciences Storm 820 Phosphorimager. Gel images were quantified using ImageQuant 5.1 software. The percent of DNA unwound is plotted as the average of three trials, and error bars represent one S.D. of the mean.
Half-maximal unwinding is defined as the concentration of protein required to unwind 50% of the substrate.
RESULTS

Comparison of EcRecQ and DrRecQ HRDC Domains-
The prototypical bacterial RecQ domain composition is defined by helicase, RecQCt, and HRDC sequence elements in order from N to C terminus. All but four of the currently identifiable bacterial RecQ protein sequences appear to conform to this general structure (data not shown). The outlying RecQ proteins are differentiated by the presence of multiple HRDC domains at their C termini. These unusual RecQ proteins are found in Rhodobacter sphaeroides (two HRDC domains) as well as in D. radiodurans, Neisseria gonorrhea, and Neisseria meningitidis (three HRDC domains). Although RecQ proteins containing a single HRDC domain appear to use this domain as a DNA substrate specificity determinant, the functions of multiple HRDC domains on RecQ helicases have not been previously investigated.
Comparison of the EcRecQ HRDC domain with the three HRDC domains of DrRecQ reveals similarities among the domains that is strongest for the first DrRecQ HRDC domain and somewhat weaker for its more C-terminal domains (Fig. 1) . The EcRecQ HRDC domain shares 65% similarity and 40% identity with DrRecQ HRDC1, 64% similarity and 36% identity with DrRecQ HRDC2, and 59% similarity and 33% identity with DrRecQ HRDC3. Of the ϳ44 residues connecting HRDC1 and HRDC2 and 21 residues connecting HRDC2 and HRDC3 of DrRecQ, one third are either proline or glycine. A total of 14 residues are invariant among the three DrRecQ and single EcRecQ HRDC domains (Fig. 1b) . The side chains from 8 of these residues are non-polar and contribute to the hydrophobic core, and 3 others are glycines that form borders of two ␣-helices in the EcRecQ HRDC domain structure (30) . The remaining 3 invariant residues (2 arginines and 1 glutamic acid) have charged side chains that map to the surface of the EcRecQ HRDC domain. Mutagenesis of the EcRecQ HRDC domain has identified 6 positively charged or aromatic residues that are important for ssDNA binding (30) . In each of the DrRecQ HRDC domains, only a subset of these residues is conserved (Fig. 1b) . Therefore, it appears that the multiple HRDC domains of D. radiodurans RecQ are not simple repetitive copies of the EcRecQ HRDC domain and each has distinguishing sequence characteristics that may confer specialized functions.
Limited Proteolysis Defines the Domain Structure of DrRecQ-To examine the low resolution domain structure of DrRecQ, we performed limited proteolysis on purified DrRecQ. The products formed by limited proteolytic treatment were analyzed by SDS-PAGE and mass spectrometry to identify proteolytically resistant domains in DrRecQ. Gel analysis of the reaction products revealed four major bands that migrated faster than full-length DrRecQ (Fig. 2a, lanes 5-9) . The estimated masses of these fragments were 85 kDa (band 1), 69 kDa (band 2), 57 kDa (band 3), and 51 kDa (band 4). MALDI-TOF mass spectrometry analysis of trypsin-derived peptide fragments from excised bands 1-4 indicated that successively fewer C-terminal peptides could be detected in the faster migrating bands (Fig. 2b) . In addition, the intensity of the C-terminal-most peptides was diminished in the higher mobility bands. These differences were consistent with proteolytic removal of individual HRDC domains from DrRecQ. More definitive N-terminal sequencing attempts failed to identify the specific protease-sensitive sites, perhaps because of heterogeneity of the fragments (data not shown).
Based on this analysis, DrRecQ variants with successive truncations of each of the HRDC domains were recombinantly produced and purified. The SDS-PAGE migration of these proteins was strikingly similar to the limited proteolysis products (Fig. 2a, lanes 1-9) , consistent with our hypothesis that the DrRecQ fragments differ by removal of one or more HRDC domains. Additional recombinant proteins containing each individual DrRecQ HRDC domain (HRDC1, HRDC2, and HRDC3), each pairwise combination (HRDC1 ϩ 2 and HRDC2 ϩ 3), and the triple HRDC sequence (3HRDC) were also purified for biochemical analysis. Circular dichroic spectra and/or structure determination of the single, double, and triple HRDC constructs indicated that the HRDC constructs were folded and highly ␣-helical (data not shown).
DNA Binding by DrRecQ Variants-The DNA binding properties of each DrRecQ variant was assessed by measuring its equilibrium binding affinity to three different synthetic DNA substrates: ssDNA, 3Ј-OH DNA, and HJ DNA. Given the many previous reports of HRDC-mediated DNA binding, the effects of removing the DrRecQ HRDC domains on its ssDNA binding affinity were surprising (Fig. 3a) . The apparent dissociation constant (K d , app) measured for DrRecQ binding to ssDNA was 12 Ϯ 2 nM. However, DrRecQ-2HRDC, which lacks HRDC3, had an increased ssDNA binding affinity (K d , app of 2.8 Ϯ 0.4 nM). Furthermore, DrRecQ-1HRDC, which lacks both HRDC2 and HRDC3, had an even greater enhancement of ssDNA binding affinity relative to full-length protein, with a K d , app of less than 1 Ϯ 0.2 nM for DrRecQ-1HRDC. An upper limit for K d , app is given because the binding experiment includes 1 nM DNA and the DrRecQ-1HRDC concentration required for halfmaximal binding is ϳ1 nM, making substrate concentration limiting and implying that the true K d for the binding reaction is below 1 nM. In contrast, removal of all three HRDC domains from DrRecQ (DrRecQ⌬C) dramatically decreases affinity for ssDNA as is evident by its 380 Ϯ 50 nM K d , app. Thus, HRDC2 and HRDC3 appear to inhibit high affinity ssDNA binding, whereas HRDC1 forms a critical ssDNA binding element when linked to the DrRecQ catalytic core domain.
To test whether the HRDC domains alone are sufficient for ssDNA binding, we measured the binding affinity of a construct comprising just the three HRDC domains (3HRDC). This construct bound ssDNA with a K d , app of ϳ47 Ϯ 1 nM. Interestingly, each of the individual HRDC domains alone and constructs composed of dual HRDC domains bound ssDNA very poorly with K d , app values in excess of 10 M (data not shown). Thus, it appears that the DrRecQ catalytic core and HRDC1 combine to form a high affinity ssDNA binding site, whereas the 3HRDC construct retains a modest ssDNA binding ability.
The apparent equilibrium ssDNA binding constants of the DrRecQ variants were somewhat salt dependent (data not shown). Relative to binding data described above (50 mM NaCl), the ssDNA binding affinity of DrRecQ was unaffected by raising the NaCl to 100 mM but was 4-fold weaker in 150 mM NaCl. ssDNA binding by DrRecQ-2HRDC and DrRecQ-1HRDC was 4 -10 fold weaker when salt concentrations in the reaction buffer were raised to 100 and 150 mM NaCl. Interestingly, ssDNA binding to DrRecQ⌬C was enhanced ϳ9-fold in 100 mM NaCl relative to 50 mM, but at 150 mM NaCl the affinity was indistinguishable from the 50 mM NaCl data. Thus, with few exceptions, higher salt concentrations reduced the ssDNA binding affinities of the DrRecQ variants.
Examination of binding to a partial duplex DNA substrate with a 3Ј-ssDNA overhang revealed a different relationship among the panel of DrRecQ variants. Although EcRecQ binds a variety of DNA structures, 3Ј-OH DNA structures, which mimic the lagging strand of a replication fork, are bound with the highest affinity (40, 41) . We therefore examined DrRecQ DNA binding to a simple 3Ј-OH DNA. DrRecQ, DrRecQ-2HRDC, and DrRecQ-1HRDC had very similar K d , app values of 49 Ϯ 9, 56 Ϯ 10, and 56 Ϯ 5 nM, respectively, on 3Ј-OH DNA (Fig. 3b) . A noticeable effect on DNA binding was observed, however, upon removal of all three HRDC domains; DrRecQ⌬C displayed a 10-fold reduction in binding affinity for the 3Ј-OH substrate. The 3HRDC construct bound 3Ј-OH DNA similarly to DrRecQ⌬C. Again, each of the individual HRDC domains, HRDC1 ϩ 2, and HRDC2 ϩ 3 had very low affinity for this substrate with K d , app values in excess of 10 M (data not shown). These binding data reinforce the idea that HRDC1 is critical for high affinity DNA binding; however, in contrast to ssDNA, HRDC2 and HRDC3 do not negatively affect 3Ј-OH DNA binding.
Finally, we measured HJ DNA binding affinity for each of the DrRecQ constructs. These DNA structures are common intermediates of recombination reactions, and several RecQ proteins are able to bind HJ DNA and catalyze branch migration reactions (reviewed in Ref. 18 ). The effects of removing DrRecQ HRDC domains on HJ binding were more complex than observed for ssDNA binding. Full-length DrRecQ binds HJ DNA with a K d , app of 8.5 Ϯ 3 nM (Fig. 3c) . Interestingly, both DrRecQ-2HRDC and DrRecQ-1HRDC exhibited apparent biphasic DNA binding behavior with HJ DNA. DrRecQ-2HRDC binds the substrate with higher affinity than full-length DrRecQ at low protein concentrations but does not reach DNA binding saturation in an apparent two-state binding reaction. DrRecQ-1HRDC binds the substrate with lower affinity than DrRecQ at all protein concentrations tested but also appears to bind HJ DNA in a complex manner. It is possible that DrRecQ-2HRDC and DrRecQ-1HRDC have multiple binding sites on the HJ substrate and interact with either the duplex arms or the fourway junction of the substrate with different affinities. Both 3HRDC and DrRecQ⌬C variants showed low affinity for the HJ substrate. As was the case with ssDNA and 3Ј-OH DNA, the individual HRDC domains, HRDC1 ϩ 2, and HRDC2 ϩ 3 have very low affinity for HJ DNA with K d , app values in excess of 10 M (data not shown). Thus, the HRDC domains of DrRecQ play different roles in binding to HJ DNA: HRDC1 and HRDC2 are required for maximal HJ binding by DrRecQ, whereas HRDC3 appears to reduce HJ binding at low protein concentrations.
Comparison of the three DNA substrates tested indicates that DrRecQ has the highest affinity for ssDNA and HJ DNA. Removal of HRDC3 increases the affinity of DrRecQ for these substrates. The presence of HRDC2 weakly decreased DrRecQ binding to ssDNA; however, its loss lowered the affinity for HJ DNA. For all three substrates, HRDC1 is required for high affinity DNA binding, and its absence results in a dramatic decrease in binding affinity. Individually purified HRDC1, HRDC2, and HRDC3 and pair-wise combinations of the domain all bind the substrates with very low affinity (Ͼ10 M).
ATPase Activity of DrRecQ Variants-To test the effects of removing DrRecQHRDCdomainsonitsATPaseactivity,wemeasuredthessDNAdependent ATPase activity of each variant. DrRecQ DNA unwinding activity precludes using more complex DNA structures as cofactors because ssDNA and double-stranded DNA differentially stimulate RecQ ATPase activity (42) . ATPase stimulation studies were therefore limited to using homopolymeric ssDNA (dT 28 ) as a cofactor.
As is the case with other RecQ helicases, each of the constructs required DNA as a cofactor to produce measurable ATP hydrolysis (Fig.  4) . Full-length DrRecQ hydrolyzed ATP with a maximal rate of 900 min Ϫ1 and is half-activated in the presence of ϳ1 nM dT 28 ; removal of either HRDC3 or both HRDC2 and HRDC3 led to an increase in the maximal ATPase rate to 1620 and 1850 min Ϫ1 , respectively. The amount of dT 28 required for half-activation of the DrRecQ-2HRDC and DrRecQ-1HRDC ATPase activities was ϳ3 nM. Although we were unable to reach a maximal hydrolysis rate for DrRecQ⌬C, it has the highest observed rate for all of the variants with an ATPase rate of 2430 min Ϫ1 at 100 nM DNA. Despite this heightened ATPase activity, DrRecQ⌬C required higher ssDNA concentrations to stimulate ATPase activity, consistent with its relatively low affinity for ssDNA (Fig. 3) .
Helicase Activity of DrRecQ Variants-Finally, we examined the DNA unwinding activity of each of the DrRecQ variants. Helicase activity requires the productive integration of DNA binding and ATP hydrolysis activities, which makes it an excellent measure of the overall effects of removing the HRDC domains from DrRecQ. Helicase activity was measured for 3Ј-OH and HJ DNA substrates. In each case, a single radiolabeled oligonucleotide was incorporated into the DNA substrate and helicase activity was assessed by the mobility of the labeled DNA on non-denaturing PAGE. The annealed DNA substrate displays retarded gel mobility relative to the unwound ssDNA product.
Full-length DrRecQ unwound 3Ј-OH DNA with half-maximal activity observed at ϳ0.1 nM enzyme concentration (Fig. 5a and supplemental Fig. S1 ). Removal of HRDC3 had no apparent effect on the ability of the enzyme to unwind this substrate. However, removal of HRDC2 and HRDC3 stimulated unwinding of 3Ј-OH DNA ϳ10-fold over fulllength DrRecQ (Fig. 5a) . DrRecQ⌬C 3Ј-OH unwinding activity was indistinguishable from that of DrRecQ-1HRDC.
DrRecQ was also able to unwind a synthetic HJ DNA substrate, albeit with a reduced efficiency relative to 3Ј-OH DNA unwinding (Fig. 5b) . Half-maximal unwinding of HJ DNA by DrRecQ required ϳ0.3 nM enzyme, 3-fold more than was required for the unwinding of the 3Ј-OH substrate. As was the case with 3Ј-OH DNA unwinding, the amount of enzyme required for half-maximal HJ DNA unwinding was unaffected by removal of HRDC3 but was significantly reduced by removal of HRDC2 and HRDC3. Activity of this variant appears to be biphasic, which could be related to its HJ binding behavior (Fig. 3) . In contrast to 3Ј-OH unwinding, removal of all three HRDC domains substantially reduced HJ DNA unwinding such that a concentration of at least 50 nM was required to unwind half of the substrate.
DISCUSSION
In this study, we tested a hypothesis that the multiple HRDC domains in DrRecQ helicase have specialized functions relative to each other and to HRDC domains from well studied single HRDC RecQ proteins. The canonical bacterial RecQ structure combines a catalytic core domain with a single HRDC domain. In contrast, four genes encoding RecQ proteins with multiple HRDC domains have been found through several genome sequencing projects, raising the possibility that the additional HRDC domains present in these RecQ family members encode unique biochemical activities. Sequence comparison among the HRDC domains of D. radiodurans and E. coli suggested that each domain likely shares a similar overall structure due to the high degree of sequence conservation. However, differences in the sequences between EcRecQ and DrRecQ HRDC domains in putative surface residues that form critical ssDNA binding elements in the E. coli enzyme suggest that the DrRecQ domains could have different functions from the currently understood roles of other HRDC domains.
Limited proteolysis experiments indicated that each DrRecQ HRDC domain forms discreetly folded modules in the enzyme (Fig. 2) . These observations led to the construction of a series of deletion variants that successively removed each DrRecQ HRDC domain. Using these variants, we found that the multiple HRDC domains of DrRecQ regulate its activity by modulating the enzyme's structure-specific DNA binding affinity, DNA-dependent ATP hydrolysis behavior, and helicase activity.
DrRecQ HRDC Domains Differentially Modulate DNA Binding and Enzymatic Activity-Full-length DrRecQ was shown to bind to HJ and ssDNA with high affinity and to 3Ј-OH DNA with a somewhat lower affinity (Fig. 3) . As is the case with EcRecQ (42, 43) , DrRecQ is competent to hydrolyze ATP in a DNA-dependent fashion (Fig. 4) and unwind HJ and 3Ј-OH DNA structures in an ATP-dependent reaction with 3Ј-OH being the preferred substrate (Fig. 5) . DrRecQ could also unwind 5Ј-OH, albeit with a significantly reduced activity relative to 3Ј-OH unwinding (data not shown).
Removal of the C-terminal-most HRDC domain from DrRecQ (HRDC3) resulted in surprising differences in activity relative to fulllength protein. Most strikingly, removal of HRDC3 produced a DrRecQ with ϳ5-fold higher affinity for ssDNA (Fig. 3) and a heightened maximal ssDNA-dependent ATPase rate (Fig. 4) . However, these enhancements did not translate to an increase in DNA unwinding activity (Fig.  5) . Together, these data suggest that DrRecQ HRDC3 plays a negative regulatory role that attenuates association of the enzyme with ssDNA. This is in stark contrast to the role played by the EcRecQ HRDC, which directly binds ssDNA (30) .
Removal of both HRDC2 and HRDC3 from DrRecQ in the DrRecQ-1HRDC protein resulted in additional functional changes. Removal of HRDC2 further enhanced ssDNA binding relative to DrRecQ-2HRDC, whereas HJ binding was impaired and 3Ј-OH binding was unaffected (Fig. 3) . DNA-dependent ATPase activity was also essentially the same as that of DrRecQ-2HRDC (Fig. 4) . Remarkably, DrRecQ-1HRDC displayed the most robust unwinding activity of the variants tested, with ϳ10-fold higher specific unwinding activity on 3Ј-OH and HJ DNA relative to full-length DrRecQ (Fig. 5) . Taken together, it appears that whereas HRDC3 inhibits ssDNA binding, removal of HRDC2 and HRDC3 stimulates myriad functions in DrRecQ. Thus, the role of DrRecQ HRDC2 is likely more complex than that of HRDC3, with properties that limit both DNA binding and unwinding.
Finally, removal of all three of the DrRecQ HRDC domains in the DrRecQ⌬C construct produced a variant with greatly weakened DNA binding ability on all substrates tested (Fig. 3) but that had the highest levels of ssDNA-dependent ATPase rates among the panel of constructs tested (Fig. 4) . Interestingly, the weaker DNA binding ability did not result in a change in 3Ј-OH unwinding capacity relative to DrRecQ-1HRDC, although HJ unwinding is greatly attenuated in the DrRecQ⌬C protein (Fig. 5) HRDC domain regulation appears to affect both structure-specific DNA binding and enzymatic activity of DrRecQ, in that HRDC2 and HRDC3 generally inhibit and HRDC1 generally stimulates these activities. A simple model to explain our data involves direct contacts between the HRDC domains and the catalytic core domain of DrRecQ. HRDC3 appears to most strongly attenuate ssDNA binding in DrRecQ. It is possible that HRDC3 directly binds a DNA binding site on DrRecQ and competes with ssDNA for binding the enzyme. In support of a competitive model, the calculated pI for HRDC3 is 4.7, indicating that it likely contains a highly electronegative surface that could potentially mimic the negative charges of DNA and compete with DNA for binding. Similar modes of DNA binding inhibition have been observed for several proteins (44) . Alternatively, HRDC3 could indirectly inhibit DNA binding by binding to and stabilizing a conformation of the enzyme with lower enzymatic and/or DNA binding activity. In contrast to HRDC3, HRDC2 primarily attenuates DrRecQ DNA unwinding. A simple competition model does not explain its role; ssDNA-dependent ATPase activity is quite similar between constructs that differ by the presence of HRDC2, and its effects on DNA binding are complex. Instead, HRDC2 appears to modulate intrinsic DrRecQ helicase activity, because its removal strongly stimulates unwinding of HJ and 3Ј-OH DNA without enhancing binding affinity. Regardless of the precise mechanisms whereby the presence of HRDC3 and HRDC2 inhibit DrRecQ activity, it is clear that these domains play negative regulatory roles. Finally, HRDC1 appears important for DNA binding and HJ DNA unwinding, making it a stimulator of DrRecQ activity. This is similar to the observed role of the single HRDC domain in EcRecQ (24, 30) . Additional potential roles of DrRecQ HRDC domains include acting as sites for proteinprotein interactions that could target the enzyme to damaged DNA structures and/or provide a cellular mechanism for regulating the actions of the HRDC domains on DrRecQ in different contexts.
DNA binding inhibition and regulation of catalytic functions of DrRecQ by HRDC2 and HRDC3 reveal a novel role for these domains in RecQ function. Single HRDC RecQ helicases use their HRDC domains as auxiliary DNA binding element; in DrRecQ, however, its additional HRDC domains have evolved more complex regulatory roles. It follows that regulation by HRDC2 and HRDC3 is likely to be important for DrRecQ function in vivo. This is consistent with the proposed central role of RecQ and a RecF-like recombination pathway in D. radiodurans cells. Genome maintenance models that include HJ and 3Ј-OH DNA structures as DSB repair intermediates have been suggested to be important in D. radiodurans (2) ; the studies presented here have demonstrated that the activity of DrRecQ on these structures is regulated by its HRDC domains. It is reasonable to speculate that the DrRecQ HRDC domains aid in substrate selection in vivo and in regulating the level of activity of the helicase in DNA structure-specific manner.
Interestingly, RecQ is not the only genome maintenance protein in D. radiodurans that has an unusual arrangement of domains playing rare regulatory roles. D. radiodurans ssDNA-binding protein (SSB) encodes an atypical domain arrangement with two DNA-binding domains per polypeptide rather than the single domain found in over 99% of other bacterial SSBs (45, 46) . This arrangement allows independent evolution of the two domains not available in the single domain SSBs that has been proposed to be important for specialized functions of the two domains in protecting exposed ssDNA (46) . Thus, duplication of a domain with subsequent selection of novel functions appears to be an evolutionary strategy that has helped shaped multiple genome maintenance proteins in D. radiodurans.
Parallels with Other Triple HRDC Domain-containing RecQ Helicases-The only other organisms identified thus far that have recQ genes with three HRDC domains are N. meningitidis and N. gonorrhea. How might the studies presented here relate to these other bacterial species? N. meningitidis and N. gonorrhea are obligate human pathogens with a high demand for recombination to facilitate antigenic variation. Antigenic variation in Neisseria is a highly active process that occurs at rates of 10 Ϫ4 to 10 Ϫ3 events/cell/generation (47) . Even though the Neisseria species do have recBCD homologs, mutation of recQ in N. gonorrhea results in severe reductions in antigenic variation and DNA repair capability (48) . This condition is reminiscent of the compromised repair of E. coli recQ mutations in a recBC-sbcB-background (49, 50) . This suggests an important role for RecQ and a RecF-like pathway in Neisseria as has been hypothesized for D. radiodurans. Thus, although Deinococcus and Neisseria species inhabit different ecological niches, their similarities suggest they may utilize similar RecQ-dependent strategies of DNA recombinational repair. It could be that these organisms require high fidelity (and highly regulated) homologous recombination reactions and have developed specialized activities for their RecQ proteins to initiate these reactions. As such, the regulatory roles of the DrRecQ HRDC domains described in this report could represent important mechanistic features of multi-HRDC domain enzymes.
